Zai Lab/ZLAB

$19.94

-0.69%
-
1D1W1MYTD1YMAX

About Zai Lab

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.
Ticker
ZLAB
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
CEO
Du Ying
Employees
2,036
Headquarters
Shanghai, China

Zai Lab Metrics

BasicAdvanced
$1.97B
Market cap
-
P/E ratio
-$3.12
EPS
1.12
Beta
-
Dividend rate

What the Analysts think about Zai Lab

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 10 analysts.
230.54% upside
High $123.00
Low $37.00
$19.94
Current price
$65.91
Average price target

Zai Lab Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-99.85% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$69.2M
0.58%
Net income
$-69.1M
-42.8%
Profit margin
-99.85%
-43.13%

Zai Lab Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 32.01%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.65
-$0.51
-$1.25
-$0.71
-
Expected
-$1.11
-$0.95
-$0.79
-$1.04
-$0.86
Surprise
-41.39%
-46.18%
58.43%
-32.01%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell Zai Lab stock

Buy or sell Zai Lab stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing